The prognostication of colorectal cancer (CRC) has traditionally relied on staging as defined
by the Union for International Cancer Control (UICC) and American Joint Committee on …

Colorectal cancer (CRC) is the second most common cause of cancer death in the world.
Both modifiable and nonmodifiable risk factors play a significant role in the pathogenesis of …

Purpose Colorectal cancer (CRC) treatment is largely determined by tumor stage. Despite
improvements made in the treatment of various types of metastatic disease, staging has not …

Purpose: We established a CT-derived approach to achieve accurate progression-free
survival (PFS) prediction to EGFR tyrosine kinase inhibitors (TKI) therapy in multicenter …

Background: We aimed to evaluate the performance of a deep learning (DL)-based
Radiomics strategy designed for analyzing contrast-enhanced ultrasound (CEUS) to not …

Introduction The systemic inflammatory response has been proven to have a prognostic
value. There are two methods of assessing the systemic inflammatory response composite …

Background: This study aimed to compare the outcomes of older and younger patients with
T4 colorectal cancer (CRC) treated with surgery. Methods: Consecutive patients with T4 …

Abstract Background and Objective: Epigenetic alterations are common events in clear cell
renal cell carcinoma (ccRCC), and protein arginine methyltransferase 1 (PRMT1) is an …

Tumor deposits (TDs) are discontinuous tumor spread in the mesocolon/mesorectum which
is found in approximately 20% of colorectal cancer (CRC) and negatively affects survival …

Young Patients (≤35years old) With Colorectal Cancer Have Wo... : Medicine Young Patients
(≤35years old) With Colorectal Cancer Have Worse Outcomes Due to More Advanced …